Premier Biomedical, Inc. (OTCQB: BIEI), a research-based company focused on the discovery and development of medical treatments for a wide range of diseases, this morning announced that it has reached an agreement with specialized holding company SinglePoint, Inc. (OTC: SING) to manufacture Premier’s new-design CBD Hemp Oil Patch in high volume. “We have been working very hard on making acquisitions and inside sales to boost revenues,” Greg Lambrecht, CEO of SinglePoint, stated in the news release. “This new business will contribute significantly to our revenue goals.” Per the update, Premier’s CBD Hemp Oil Skin Patch is expected to be the first in a line of products stemming from the agreement, as the two companies envision additional products being included in the near future. “We are excited that we found a volume supplier for our products,” William A. Hartman, president and CEO of Premier, stated in the news release. “We look forward to working with SinglePoint to continue building current and future planned new products.”
Read the full article
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Read More